Development of a BALB/c 3T3 neutral red uptake cytotoxicity test using a mainstream cigarette smoke exposure system

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Thorne, David ^a   Kilford, Joanne ^b   Payne, Rebecca ^b   Haswell, Linsey ^a   Dalrymple, Annette ^a   Meredith, Clive ^a   Dillon, Deborah ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b Department of Genetic and Molecular Toxicology   (United Kingdom)

Author keywords

BALB c3T3; Gas vapour phase; Neutral red; Smoke exposure system; Tobacco smoke; Whole smoke

Indexed keywords

NEUTRAL RED; SMOKE;

3T3 CELL LINE; ANIMAL; BAGG ALBINO MOUSE; METABOLISM; MOUSE; SMOKE; TOBACCO;

3T3 CELLS; ANIMALS; MICE; MICE, INBRED BALB C; NEUTRAL RED; SMOKE; TOBACCO;

EID: 84902300256     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-367     Document Type: Article

References (29)

1. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Wan J, Johnson M, Schilz J, Djordjevic M, Rice J, Shields P, Cancer Epidemiol Biomarkers Prev 2009 18 2363 3304
2. The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assays. Crooks I, Dillon D, Scott K, Ballantyne M, Meredith C, Regul Toxicol Pharmacol 2013 65 196 200 10.1016/j.yrtph.2012.11.012 23220485
3. A review of in vitro methods to assess the biological activity of tobacco smoke with the aim of reducing the toxicology of smoke. Andreoli C, Gigante D, Nunziata A, Toxicol in Vitro 2003 17 587 594 10.1016/S0887-2333(03)00091-2 14599449
4. Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review. Bakland S, Winder C, Khalil C, Hayes A, Inhal Toxicol 2005 17 775 787 10.1080/08958370500225240 16195213
5. Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. International Conference on Harmonization (ICH), http://www.ich.org/products/guidelines/safety/safety- single/article/guidance-on-genotoxicity-testing-and-data-interpretation-for- pharmaceuticals-intended-for-human-use.html
6. Guidance on a strategy for genotoxicity testing of chemical substances. Committee on Mutagenicity (COM 2011), http://www.iacom.org.uk/guidstate/ documents/COMGuidanceFINAL2.pdf
7. Regulations amending the tobacco reporting regulations. Health Canada, http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/legislation/reg/indust/index-eng.php
8. Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA). http://www.coresta.org/Reports/IVT-TF-Rationale-IVT-Testing-Tob.-Smoke-Report- Jun04.pdf
9. Rodgman A, Perfetti TA, The chemical components of Tobacco and Tobacco smoke CRC Press 2 2013 Chapter 28. ISBN: 978-1-4200-7883-1
10. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Fowles J, Dybing E, Tob Control 2003 12 424 430 10.1136/tc.12.4.424 14660781
11. The changing cigarette, 1950-1995. Hoffmann D, Hoffmann I, J Toxicol Environ Health 1997 50 307 364 10.1080/009841097160393 9120872
12. In vitro micronucleus assay for cigarette smoke using a whole smoke exposure system: a comparison of smoking regimens. Okuwa K, Tanaka M, Fukano Y, Nara H, Nishijima Y, Nishino T, Exp Toxicol Pathol 2010 62 433 440 10.1016/j.etp.2009.06.002 19560909
13. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Aufderheide M, Knebel JW, Ritter D, Exp Toxicol Pathol 2003 55 51 57 10.1078/0940-2993-00298 12940629
14. Characterization of a whole smoke in vitro exposure system (Burghart Mimic Smoker-01). Scian MJ, Oldham MJ, Kane DB, Edmiston JS, McKinney WJ, Inhal Toxicol 2009 21 234 243 10.1080/08958370802482515 19016061
15. Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Phillips J, Kluss B, Richter A, Massey E, Altern Lab Anim 2005 33 239 248 16180978
16. ICCVAM test method method evaluation report. In vitro cytotoxicity test methods for estimating starting doses for acute oral systemic cytotoxicity. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), http://ntp.niehs.nih.gov/iccvam/docs/acutetox-docs/brd-tmer/at-tmer- complete.pdf
17. Cigarette smoke deposition in a Vitrocell® exposure module: real-time quantification in vitro using quartz crystal microbalances. Adamson J, Thorne D, Dalrymple A, Dillon D, Meredith C, Chem Cent 2013 7 50 10.1186/1752-153X-7-50
18. Comet assay and air-liquid interfae exposure system: a new combination to evaluate genotoxic effects of cigarette whole smoke in human lung cell lines. Webber S, Hebestreit M, Conroy L, Rodrigo R, Toxicol in Vitro 2013 27 6 1987 1991 10.1016/j.tiv.2013.06.016 23845897
19. Mainstream smoke chemistry and in vivo and in vitro toxicity of the reference cigarettes 3R4F and 2R4F. Roemer E, Schramke H, Weiler H, Buettner A, Kausche S, Weber S, Berges A, Stueber M, Muench M, Trelles-Sticken E, Pype J, Kohlgrueber K, Voelkel H, Wittke S, Beiträge zur Tabakforschung International/Contributions to Tobacco Research 2012 25 1 317 335
20. Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells. Newland N, Richter A, Toxicol in Vitro 2008 22 1782 1788 10.1016/j.tiv.2008.07.009 18684396
21. Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia. Haswell LE, Hewitt K, Thorne D, Richter A, Gaça M, Toxicol in Vitro 2010 24 981 987 10.1016/j.tiv.2009.12.019 20060463
22. Modified procedure of a direct in vitro exposure system for mammalian cells to whole cigarette smoke. Fukano Y, Ogura M, Eguchi K, Shibagaki M, Suzuki M, Exp Toxicol Pathol 2004 55 317 323 10.1078/0940-2993-00341 15088633
23. Detection of the cytotoxicity of water-insoluble fraction of cigarette smoke by direct exposure to cultured cells at an air-liquid interface. Nara H, Fukano Y, Nishino T, Aufderheide M, Exp Toxicol Pathol 2013 65 5 683 688 10.1016/j.etp.2012.08.004 22999638
24. Comparative assessment of toxicities of mainstream smoke from commercial cigarettes. Ritter D, Knebel J, Aufderheide M, Inhal Toxicol 2004 16 1 1 10 10.1080/08958370490271340 14744660
25. An ex vivo approach to the differentail parenchymal responses induced by cigarette whole smoke and its vapor phase. Lin J, Roy J, Verreault J, Talbot S, Côte F, Couture R, Morin A, Toxicology 2012 293 125 131 10.1016/j.tox.2012.01.004 22266391
26. Evaluation of the genotoxic and cytotoxic potential of mainstream whole smoke and smoke condensate from a cigarette containing a novel carbon filter. Bombick D, Bombick R, Ayres P, Putman K, Avalos J, Borgerding M, Doolittle D, Fundam Appl Toxicol 1997 39 1 11 17 10.1006/faat.1997.2334 9325023
27. A review of in vitro cigarette smoke exposure systems. Thorne D, Adamson J, Exp Toxicol Pathol 2013 65 1183 1193 10.1016/j.etp.2013.06.001 23850067
28. Reduction of aldehydes and hydrogen cyanide yields in mainstream cigarette smoke using an amine functionalised ion exchange resin. Branton P, McAdam K, Winter D, Liu C, Duke M, Proctor C, Chem Cent J 2011 5 15 10.1186/1752-153X-5-15 21463512
29. The use of a novel treatment process to reduce toxicant yields in cigarette smoke. Liu C, DeGrandpre Y, Porter A, Griffiths A, McAdam K, Voisine R, Cote F, Proctor C, Food Chem Toxicol 2011 49 1904 1917 10.1016/j.fct.2011.02. 015 21414707